Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease

Sleep Med. 2023 Sep:109:1-3. doi: 10.1016/j.sleep.2023.06.006. Epub 2023 Jun 17.

Abstract

Objective: while obstructive sleep apnea is strongly associated with incident cardiovascular diseases (CVD), the underlying mechanisms remain to be elucidated. This study aimed to compare the patterns of microRNAs expression between OSA and control patients with and without incident CVD.

Methods: 218 matched adult participants with and without OSA and with and without incident CVD were selected from two independent community-based prospective cohorts in France and Switzerland, and 168 microRNAs on average were detected per sample. OSA was diagnosed using the validated Berlin questionnaire in one study (Paris Prospective Study 3) and during a full-night polysomnography in the second study (HypnoLaus Study).

Results: there were 78 OSA patients (39 with and 39 without CVD) and 140 controls (70 with and 70 without CVD). Participants were male in 54.6% (n = 119) and mean age was 58.7 years (±9.2). Of the 183 miRNAs screened, a mean 168 assays were detected per sample, and 129 in all samples. There was no pattern of blood microRNAs expression that discriminated OSA patients with and without CVD events.

Conclusions: this binational study failed to find any association between a large panel of microRNAs and OSA patients with and without incident CVD.

Keywords: Cardiovascular disease; Sleep apnea; microRNA.

MeSH terms

  • Adult
  • Cardiovascular Diseases* / complications
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / genetics
  • Female
  • Humans
  • Male
  • MicroRNAs*
  • Middle Aged
  • Polysomnography
  • Prospective Studies
  • Risk Factors
  • Sleep Apnea, Obstructive* / complications
  • Sleep Apnea, Obstructive* / epidemiology
  • Sleep Apnea, Obstructive* / genetics

Substances

  • MicroRNAs